Emerging biochemical targets in chronic pain: bridging molecular mechanisms and public health policy in the Indian context.
INTRODUCTION India confronts a chronic-pain paradox widespread under-treatment of pain coexisting with intense restriction of opioid prescribing. India's prevailing opioid-constrained pain-management model, constrained by narcotic legislation, institutional caution, and cultural stigma, is biochemically and clinically...